“
We want to meet with potential investors , explore manufacturing and distribution partnership opportunities , and establish contacts with regional hospitals , clinics , and dermatology specialists .
Your views on India ’ s fast growing biotech and medtech industries ? How do you look at the business environment ?
India ' s biotech and medtech industries are expected to continue to grow in the coming years , driven by factors such as an increasing focus on quality healthcare , a large pool of skilled workers , advancements in technology , and favorable government policies .
This is very exciting from our perspective as a
Our focus on pigmentation is entirely complementary to skin bioengineering ” growing biotech and why we will be present at this year ’ s World Start-up funding festival Convention in Delhi .
Where do you see your company in the next five years ?
In the next five years our goal is to have the personalized skin graft denovoSkin™ available to patients and surgeons for the treatment of severe skin injuries , and to have machines available around the world to bioengineer the denovoSkin™ . We will also continue our research and development in skin pigmentation , tissue engineering , and automation , driven by our subsidiary in France , CUTISS Innovation .
Looking further ahead , we know that our machine technology can represent a platform that can go beyond skin ( into other tissues ), as well as beyond medicine , for example , in agritech and fashiontech .
HealthTech
BIOVOICENEWS . COM 59